American Shared Hospital Services (NYSEAMERICAN:AMS) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of American Shared Hospital Services (NYSEAMERICAN:AMS) in a research report released on Wednesday morning. The brokerage issued a hold rating on the stock.

American Shared Hospital Services Price Performance

Shares of AMS stock opened at $3.17 on Wednesday. The company has a current ratio of 1.98, a quick ratio of 1.98 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $20.07 million, a PE ratio of 39.63 and a beta of 0.70. American Shared Hospital Services has a fifty-two week low of $2.16 and a fifty-two week high of $3.69.

American Shared Hospital Services (NYSEAMERICAN:AMS) last posted its earnings results on Tuesday, May 14th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.01). The company had revenue of $5.22 million for the quarter, compared to analyst estimates of $5.01 million. American Shared Hospital Services had a return on equity of 4.29% and a net margin of 2.50%. As a group, equities analysts predict that American Shared Hospital Services will post 0.29 earnings per share for the current fiscal year.

Institutional Trading of American Shared Hospital Services

A hedge fund recently bought a new stake in American Shared Hospital Services stock. Empowered Funds LLC bought a new position in shares of American Shared Hospital Services (NYSEAMERICAN:AMS) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 10,468 shares of the company’s stock, valued at approximately $31,000. Empowered Funds LLC owned 0.17% of American Shared Hospital Services as of its most recent SEC filing. Institutional investors and hedge funds own 23.16% of the company’s stock.

About American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia.